Transport of ACE Inhibitory Peptides Ile-Gln-Pro and Val-Glu-Pro Derived from Spirulina platensis Across Caco-2 Monolayers

Journal of Food Science

Volumn 83, Issue 10, 2018, Pages 2586-2592

  He, Yuan Yuan ^a,b   Li, Tao Tao ^a   Chen, Jia Xin ^a   She, Xing Xing ^a   Ren, Di Feng ^a   Lu, Jun ^b  

^a BEIJING FORESTRY UNIVERSITY   (China)

^b NATIONAL RESEARCH INSTITUTE FOR FAMILY PLANNING   (China)

Author keywords

Caco 2 cells; Ile Gln Pro; paracellular transport; Val Glu Pro

Indexed keywords

ANTIHYPERTENSIVE AGENT; DIPEPTIDE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; GLYCYLPROLINE; PEPTIDE; PROLYLGLUTAMIC ACID; PROLYLISOLEUCINE; PROLYLVALINE;

CACO-2 CELL LINE; HUMAN; HYPERTENSION; INTESTINE MUCOSA; METABOLISM; PATHOPHYSIOLOGY; SPIRULINA; TRANSPORT AT THE CELLULAR LEVEL;

ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; BIOLOGICAL TRANSPORT; CACO-2 CELLS; DIPEPTIDES; HUMANS; HYPERTENSION; INTESTINAL MUCOSA; PEPTIDES; SPIRULINA;

EID: 85053541396     PISSN: 00221147     EISSN: 17503841     Source Type: Journal    
DOI: 10.1111/1750-3841.14350     Document Type: Article

References (47)

1. Adibi, S. A. (2003). Regulation of expression of the intestinal oligopeptide transporter (Pept-1) in health and disease. American Journal of Physiology-Gastrointestinal and Liver Physiology, 285(5), 779–788
2. Adson, A., Raub, T. J., Burton, P. S., Barsuhn, C. L., Hilgers, A. R., Audus, K. L., & Ho, N. F. H. (1994). Quantitative approaches to delineate paracellular diffusion in cultured epithelial-cell monolayers. Journal of Pharmaceutical Sciences, 83, 1529–1536
3. Aito-Inoue, M., Lackeyram, D., Fan M, Z., Sato, K., & Mine, Y. (2007). Transport of a tripeptide, Gly-Pro-Hyp, across the porcine intestinal brush-border membrane. Journal of Peptide Science, 13(7), 468–474
4. Artursson, P., Palm, K., & Luthman, K. (2001). Caco-2 monolayers in experimental and theoretical predictions of drug transport. Advanced Drug Delivery Reviews, 46, 27–43
5. Barberis, S. E., Origone, A. L., Adaro, M. O., & Bersi, G. (2018). Bioactive peptides as functional food ingredients. In Role of materials science in food bioengineering (pp. 147–186). New York, NY: Academic Press
6. Bejjani, S., Pullakhandam, R., Punjal, R., & Nair, K. M. (2007). Gastric digestion of pea ferritin and modulation of its iron bioavailability by ascorbic and phytic acids in Caco-2 cells. World Journal of Gastroenterology, 13(14), 2083–2088
7. Bejjani, S., & Wu, J. P. (2013). Transport of IRW, an ovotransferrin-derived antihypertensive peptide, in human intestinal epithelial Caco-2 cells. Journal of Agricultural and Food Chemistry, 61(7), 1487–1492
8. Brodin, B., Nielsen, C. U., Steffansen, B., & Frokjaer, S. (2002). Transport of peptidomimetic drugs by the intestinal di/tri-peptide transporter, PepT 1. Pharmacology and Toxicology, 90, 285–296
9. Burton, P. S., Conradi, R. A., Hilgers, A. R., & Ho, A. N. (1993). Evidence for a polarized efflux system for peptides in the apical membrane of Caco-2 cells. Biochemical and Biophysical Research Communications, 190(3), 760–766
10. Chockalingam, A., Campbell, N. R., & Fodor, J. G. (2006). Worldwide epidemic of hypertension. Canadian Journal of Cardiology, 22(7), 553–555
11. Daniel, H. (2004). Molecular and integrative physiology of intestinal peptide transport. Annual Review of Physiology, 66, 361–384
12. Ding, L., Zhang, Y., Jiang, Y., Wang, L. Y., Liu, B. Q., & Liu, J. B. (2014). Transport of egg white ACE-inhibitory peptide, Gln-Ile-Gly-Leu-Phe, in human intestinal Caco-2 cell monolayers with cytoprotective effect. Journal of Agricultural and Food Chemistry, 62(14), 3177–3182
13. Fu, Y., Young, J. F., Rasmussen, M. K., Dalsgaard, T. K., Lametsch, R., Aluko, R. E., & Therkildsen, M. (2016). Angiotensin I-converting enzyme-inhibitory peptides from bovine collagen: Insights into inhibitory mechanism and transepithelial transport. Food Research International, 89, 373–381
14. Gao, J. J., Guo, Y. X., & Pan, D. D. (2017). Intestinal absorption of milk-derived ace inhibitory peptides LL and LPEW using Caco-2 cell model. Shipin Kexue/Food Science, 38(11), 214–219 (in Chinese)
15. Hubatsch, I., Ragnarsson, E. G. E., & Artursson, P. (2007). Determination of drug permeability and prediction of drug absorption in Caco-2 monolayers. Nature Protocols, 2(9), 2111–2119
16. Hidalgo, I. J., Raub, T. J., & Borchardt, R. T. (1989). Characterization of the human colon carcinoma cell line (Caco-2) as a model system for intestinal epithelial permeability. Gastroenterology, 96(3), 736–749
17. Irvine, J. D., Takahashi, L., Lockhart, K., Cheong, J., Tolan, J. W., Selick, H. E., & Russell, G. J. (1999). MDCK (Madin-Darby canine kidney) cells: A tool for membrane permeability screening. Journal of Pharmaceutical Sciences, 88(1), 28–33
18. Kim, D. C., Burton, P. S., & Borchardt, R. T. (1993). A correlation between the permeability characteristics of a series of peptides using an in vitro cell culture model (Caco-2) and those using an in situ perfused rat ileum model of the intestinal mucosa. Pharmaceutical Research, 10(12), 1710–1714
19. Kovacs-Nolan, J., Zhang, H., Ibuki, M., Nakamori, T., Yoshiura, K., Turner, P. V., … Mine, Y. (2012). The PepT1-transportable soy tripeptide VPY reduces intestinal inflammation. Biochimica et Biophysica Acta (BBA)-General Subjects, 18, 1753–1763
20. Lehmann, T., Köhler, C., Weidauer, E., Taege, C., & Foth, H. (2001). Expression of MRP1 and related transporters in human lung cells in culture. Toxicology, 167(1), 59–72
21. Li, Y., Zhao, J. T., Liu, X. L., Xia, X. D., Wang, Y., & Zhou, J. Z. (2017). Transport of a novel angiotensin-I-converting enzyme inhibitory peptide Ala-His-Leu-Leu across human intestinal epithelial Caco-2 cells. Journal of Medicinal Food, 20(3), 243–250
22. Lip, G. Y., & Ferner, R. E. (1995). Poisoning with anti-hypertensive drugs: Beta-adrenoceptor blocker drugs. Journal of Human Hypertension, 9(4), 213–221
23. Litman, T., Druley, T. E., Stein, W. D., & Bates, S. E. (2001). From MDR to MXR: New understanding of multidrug resistance systems, their properties and clinical significance. Cellular and Molecular Life Sciences, 58(7), 931–959
24. Liu, Y., & Hu, M. (2002). Absorption and metabolism of flavonoids in the caco-2 cell culture model and a perused rat intestinal model. Drug Metabolism and Disposition, 4, 370–377
25. Lu, J., Ren, D. F., Xue, Y. L., Sawano, Y., Miyakawa, T., & Tanokura, M. (2010a). Isolation of an antihypertensive peptide from alcalase digest of Spirulina platensis. Journal of Agricultural and Food Chemistry, 58(12), 7166–7171
26. Lu, J., Ren, D. F., Wang, J. Z., & Tanokura, M. (2010b). Purification and characterization of an angiotensin I-converting enzyme inhibitory peptide derived from Spirulina platensis. Progress in Biochemistry and Biophysics, 37, 568–574
27. Lu, J., Yang, Y., Chen, L., Ren, D. F., Egashira, Y., & Tanokura, M. (2011a). In vivo antihypertensive effect of Val-Glu-Pro in spontaneously hypertensive rats. Progress in Biochemistry and Biophysics, 38(4), 353–360
28. Lu, J., Sawano, Y., Miyakawa, T., Xue, Y., L Cai, M. Y., Egashira, Y., … Tanokura, M. (2011b). One-week antihypertensive effect of Ile-Gln-Pro in spontaneously hypertensive rats. Journal of Agricultural and Food Chemistry, 59(2), 559–563
29. Martínez-Galero, E., Pérez-Pastén, R., Perez-Juarez, A., Fabila-Castillo, L., Gutiérrez-Salmeán, G., & Chamorro, G. (2016). Preclinical antitoxic properties of Spirulina (Arthrospira). Pharmaceutical Biology, 54(8), 1345–1353
30. Meerloo, J. V., Kaspers, G. J. L., & Cloos, J. (2011). Cell sensitivity assays: The MTT assay. Methods in Molecular Biology, 731, 237–245
31. Miguel, M., Dávalos, A., Manso, M. A., Peña, G., Lasunción, M. A., & López-Fandiño, R. (2008). Transepithelial transport across Caco-2 cell monolayers of antihypertensive egg-derived peptides. PepT1-mediated flux of Tyr-Pro-Ile. Molecular Nutrition & Food Research, 52(12), 1507–1513
32. Pagliara, A., Reist, M., Geinoz, S., Carrupt, P. A., & Testa, B. (1999). Evaluation and prediction of drug permeation. Journal of Pharmacy and Pharmacology, 51(12), 1339–1357
33. Pan, H. L., She, X. X., Wu, H. L., Ma, J., Ren, D. F., & Lu, J. (2015). Long-term regulation of the local renin-angiotensin system in the myocardium of spontaneously hypertensive rats by feeding bioactive peptides derived from Spirulina platensis. Journal of Agricultural and Food Chemistry, 63(35), 7765–7774
34. Quirós, A., Dávalos, A., Lasunción, M. A., Ramosa, M., & Recio, I. (2008). Bioavailability of the antihypertensive peptide LHLPLP: Transepithelial flux of HLPLP. International Dairy Journal, 18(3), 279–286
35. Raine, A. E. G., & Ledingham, J. G. G. (1982). Clinical experience with captopril in the treatment of severe drug-resistant hypertension. The American Journal of Cardiology, 49(6), 1475–1479
36. Regazzo, D., Molle, D., Gabai, G., Tome, D., Dupont, D., Leonil, J., & Boutrou, R. (2010). The (193–209) 17-residues peptide of bovine beta-casein is transported through Caco-2 monolayer. Molecular Nutrition & Food Research, 54(10), 1428–1435
37. Sano, J., Ohki, K., Higuchi, T., Aihara, K., Mizuno, S., Kajimoto, O., … Nakamura, Y. (2005). Effect of casein hydrolysate, prepared with protease derived from Aspergillus oryzae, on subjects with high-normal blood pressure or mild hypertension. Journal of Medicinal Food, 8, 423–430
38. Saranraj, P., & Sivasakthi, S. (2014). Spirulina platensis-food for future: A review. Asian Journal of Pharmacy and Technology, 4(1), 26–33
39. Satake, M., Enjoh, M., Nakamura, Y., Takano, T., Kawamura, Y., Arai, S., & Shimizu, M. (2002). Transepithelial transport of the bioactive tripeptide, Val-Pro-Pro, in human intestinal Caco-2 Cell monolayers. Bioscience, Biotechnology, and Biochemistry, 66(2), 378–384
40. Shimizu, K., Sato, M., Zhang, Y., Kouguchi, T., Takahata, Y., Morimatsu, F., & Shimizu, M. (2010). The bioavailable octapeptide Gly-Ala-Hyp-Gly-Leu-Hyp-Gly-Pro stimulates nitric oxide synthesis in vascular endothelial cells. Journal of Agricultural and Food Chemistry, 58, 6960–6965
41. Soheili, M., & Khosravi-Darani, K. (2011). The potential health benefits of algae and micro algae in medicine: A review on Spirulina platensis. Current Research in Nutrition and Food Science, 7, 279–285
42. Sun, H., Liu, D., Li, S., & Qin, Z. (2009). Transepithelial transport characteristics of the antihypertensive peptide, Lys-Val-Leu-Pro-Val-Pro, in human intestinal Caco-2 cell monolayers. Bioscience, Biotechnology, and Biochemistry, 73, 293–298
43. Vo, T. S., Ryu, B. M., & Kim, S. K. (2013). Purification of novel anti-inflammatory peptides from enzymatic hydrolysate of the edible microalgal Spirulina maxima. Journal of Functional Foods, 5(3), 1336–1346
44. Vermeirssen, V., Augustijns, P., Morel, N., Van Camp, J., Opsomer, A., & Verstraete, W. (2005). In vitro intestinal transport and antihypertensive activity of ACE inhibitory pea and whey digests. International Journal of Food Sciences and Nutrition, 56(6), 415–430
45. Wu, Q., Lian, L., Miron, A., Miron, A., Klímová, B., Wan, D., & Kuča, K. (2016). The antioxidant, immunomodulatory, and anti-inflammatory activities of Spirulina: An overview. Archives of Toxicology, 90(8), 1817–1840
46. Yee, S. (1997). In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man fact or myth. Pharmaceutical Research, 14(6), 763–766
47. Zhu, Q., Guo, Y. X., Pan, D. D., Zeng, X. Q., Sun, Y. Y., & Zhou, H. M. (2014). Establishment of Caco-2 cell model and intestinal absorption mechanism of the antihypertensive peptides Val-Pro-Pro and Ile-Pro-Pro. Shipin Kexue/Food Science, 35(15), 226–231 (in Chinese)